AAA August 2012 – Page 4

GE exits Riemser Arzneimittel

Axa Private Equity, a France-based subsidiary of a local insurer, has acquired Riemser Arzneimittel, a Germany-based specialty pharmaceutical company, from its minority shareholders that include US-listed industrial conglomerate General Electric’s GE Healthcare Financial Services subsidiary. Axa said it bought the shareholdings of Riemser’s founding Braun family and those of various minority stakeholders, including TVM Capital.… Continue reading GE exits Riemser Arzneimittel

Companies chipper about Mapper

Mapper Lithography, a Netherlands-based chip equipment provider founded in 2000, has gained €80m ($100m) from a consortium including Russian state-backed venture capital fund Rusnano. Rusnano, a $10bn fund which invests in US and Russian companies so they will set up operations in Russia (Bloomberg Story), will provide half the round. The remaining €40m is coming… Continue reading Companies chipper about Mapper

Fate has another $9m in store

In May last year, Japan-based drugs company Takeda Pharmaceutical’s corporate venturing unit made an equity investment of undisclosed size in Fate Therapeutics as part of a plan to help its parent move into regenerative medicines.

White Bull – Pathways to Exit – Barcelona October 1 – 3

  White Bull Summits presents its third annual summit, focusing on European Innovation in the Technology, Media, and Telecommunications sector. This year’s 2 1/2-day summit will explore the business lifecycle, and the various “Pathways” from Startup to Exit, assembling some of the brightest stars in the Industry. We’ll hear from the Global leaders, the investors, the visionaries, and the brave… Continue reading White Bull – Pathways to Exit – Barcelona October 1 – 3